12 July 2017 2 Min Read
Mediclinic merger may be blocked
Commission recommends prohibition of Matlosana deal on concern about less competition and higher tariffs
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In